CTLT
Catalent is a leading global contract development and manufacturing organization (CDMO) that partners with pharma, biotech and self-care brands to accelerate the development, manufacturing, and delivery of therapies and consumer health products. The company provides end-to-end pharmaceutical solutions across multiple modalities, including biologics, cell and gene therapies, and oral and specialty dosage forms, with a worldwide network and advanced technologies. Its scope covers early-stage development through commercial manufacturing, supporting clients in bringing life-changing medicines and self-care products to market. Headquartered with a global presence, Catalent serves customers across regions worldwide.
No recent deals for this company.